Page last updated: 2024-08-24

epigallocatechin gallate and Atrophy

epigallocatechin gallate has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Fang, L; Huang, J; Ou, K; Wang, C; Wang, Q; Xia, S; Zhang, S1
Bellmann-Strobl, J; Brandt, AU; Chien, C; Dörr, J; Klumbies, K; Lorenz, M; Paul, F; Rust, R; Scheel, M; Wernecke, KD; Wuerfel, J; Zimmermann, H1

Trials

1 trial(s) available for epigallocatechin gallate and Atrophy

ArticleYear
Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial.
    Neurology(R) neuroimmunology & neuroinflammation, 2021, Volume: 8, Issue:3

    Topics: Administration, Oral; Adult; Atrophy; Brain; Catechin; Disease Progression; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Outcome Assessment, Health Care; Random Allocation

2021

Other Studies

1 other study(ies) available for epigallocatechin gallate and Atrophy

ArticleYear
EGCG exposure during pregnancy affects uterine histomorphology in F1 female mice and the underlying mechanisms.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2022, Volume: 167

    Topics: Animals; Atrophy; Catechin; Female; Fibrosis; Inflammation; Mice; Mice, Inbred C57BL; Pregnancy; Tea

2022